Vertex Pharmaceuticals Incorporated
VRTX
$552.99
$5.400.99%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 11.62% | -6.37% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 11.62% | -6.37% | |||
| Cost of Revenue | 9.49% | -5.92% | |||
| Gross Profit | 13.38% | -6.73% | |||
| SG&A Expenses | 17.93% | 1.38% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 11.75% | -4.08% | |||
| Operating Income | 11.41% | -9.86% | |||
| Income Before Tax | 11.09% | -5.87% | |||
| Income Tax Expenses | 31.83% | 58.33% | |||
| Earnings from Continuing Operations | 6.63% | -13.41% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 6.63% | -13.41% | |||
| EBIT | 11.41% | -9.86% | |||
| EBITDA | 10.92% | -7.23% | |||
| EPS Basic | 6.80% | -13.48% | |||
| Normalized Basic EPS | 13.97% | -9.58% | |||
| EPS Diluted | 7.21% | -13.54% | |||
| Normalized Diluted EPS | 14.28% | -9.58% | |||
| Average Basic Shares Outstanding | -0.16% | 0.08% | |||
| Average Diluted Shares Outstanding | -0.43% | 0.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||